Clearmind Medicine Inc CMND

$6.10 -0.17 (-2.64%)

Valuation

Market cap
3,176,000
Revenue TTM
$0
Net income TTM
$-3,860,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.13

Trading

Volume
2,300
Avg volume
71,918
Day's range
$6.10 – $6.36
Shares out
507,000
Stochastic %K
44%
Beta
0.93
Analysts
Strong Buy
Price target
—

Price

Company profile

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound...

Show more

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; and CM-CMND-001 which is in Phase I/IIa clinical trial for the treatment of alcohol use disorder. In addition, the company has a strategic collaboration with SciSparc Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Polyrizon Ltd., and NeuroThera Labs Inc. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
973 536 1016
Website
https://www.clearmindmedicine.com
Address
1220 West 6th Avenue, Suite 101, Vancouver, Canada

Latest news

Stocktwits

focafoca99 Oct 16, 8:17 PM
$CMND sold $2 M of convertible promissory notes at 90% of principal, closing by Oct 19.
0 replies
dogood Oct 16, 9:12 AM
$CMND scam scam
0 replies
mikejohns777 Oct 15, 11:56 AM
$CMND You have to be on drugs that make you see things if you expect anything postive here! Don’t do drugs, kids.
0 replies
VK_10X Oct 12, 7:12 PM
$CMND just fyi, this shit is restricted from Robinhood to trade….
0 replies
hemlock17 Oct 12, 1:14 PM
$CMND this double diluted shit sandwich fake psychedelics Company can put out NRS about EV‘s and the new plug They’ve got all day long but it’ll still not change a thing. Total shit sandwich.
0 replies
MrTicker Oct 12, 11:58 AM
$CMND Clearmind Medicine's Charging Robotics Subsidiary Rolls Out Autonomous Vehicle Charging Platform BENZINGA 6:56 AM ET 10/12/2026
0 replies
MrTicker Oct 12, 11:55 AM
$CMND Vancouver, Canada, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc.(CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation psychedelic, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that Charging Robotics Ltd. (“Charging Robotics”), its 51%-owned subsidiary, has launched the next generation of its autonomous vehicle charging platform, designed for robotaxis, autonomous fleets and automated parking facilities.
0 replies
dogood Oct 12, 11:55 AM
$CMND same scam news
0 replies